Literature DB >> 17384658

Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients.

C Heining1, A Spyridonidis, E Bernhardt, J Schulte-Mönting, D Behringer, C Grüllich, A Jakob, H Bertz, J Finke.   

Abstract

Here we investigated the influence of parameters known before hematopoietic stem cell transplantation (HSCT) as well as the relevance of graft-versus-host disease (GvHD) and cytomegalovirus (CMV) reactivation on post transplant lymphocyte reconstitution in 148 patients treated in our institution between 1996 and 2003. Median patient age was 42 (19-68) years, HSCT followed standard high dose (n=91) or reduced-intensity conditioning regimens (n=57) with bone marrow (BM, n=67) or peripheral blood stem cells (PBSC, n=81) from related (n=71) or unrelated (n=77) donors. In the first months, we observed a partially faster reconstitution of CD3+4+, CD3+8+ and CD4+45RA+ T cells in patients following peripheral blood stem cell transplantation when compared to bone marrow transplantation. Prolonged CD3+4+ and CD4+45RA+ lymphopenia was noted after unrelated donor HSCT and GvHD prophylaxis containing anti-T-lymphocyte globulin. Lymphocyte subset counts in patients older than the median age were comparable to those in patients transplanted at a younger age and not influenced by the conditioning regimen. CD3+8+ T cell reconstitution was strongly correlated with CMV reactivation, but not significantly affected by CMV serostatus before HSCT. Incidence or extent of GvHD did not significantly influence lymphocyte reconstitution. Therefore, the source of graft is the most predictive parameter in early lymphocyte reconstitution, but the differences in lymphocyte recovery completely resolved within the first year after HSCT.

Entities:  

Mesh:

Year:  2007        PMID: 17384658     DOI: 10.1038/sj.bmt.1705648

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  25 in total

1.  Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation.

Authors:  Raphael Itzykson; Marie Robin; Helene Moins-Teisserenc; Marc Delord; Marc Busson; Aliénor Xhaard; Flore Sicre de Fontebrune; Régis Peffault de Latour; Antoine Toubert; Gérard Socié
Journal:  Haematologica       Date:  2014-09-26       Impact factor: 9.941

Review 2.  Concise review: hematopoietic stem cell aging and the prospects for rejuvenation.

Authors:  Martin Wahlestedt; Cornelis Jan Pronk; David Bryder
Journal:  Stem Cells Transl Med       Date:  2014-12-29       Impact factor: 6.940

3.  Low blood lymphocyte count at 30 days post transplant predicts worse acute GVHD and survival but not relapse in a large retrospective cohort.

Authors:  Z Gul; E Van Meter; M Abidi; I Ditah; M Abdul-Hussein; A Deol; L Ayash; L G Lum; E K Waller; V Ratanatharathorn; J Uberti; Z Al-Kadhimi
Journal:  Bone Marrow Transplant       Date:  2015-01-19       Impact factor: 5.483

4.  Graft-versus-tumor effect after allogeneic stem cell transplantation in HIV-positive patients with high-risk hematologic malignancies.

Authors:  David Serrano; Pilar Miralles; Pascual Balsalobre; Mi Kwon; Gabriela Rodriguez-Macias; Jorge Gayoso; Javier Anguita; Ismael Buño; Juan Berenguer; José L Díez-Martín
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-24       Impact factor: 2.205

5.  Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant.

Authors:  Jenna D Goldberg; Junting Zheng; Ravin Ratan; Trudy N Small; Kuan-Chi Lai; Farid Boulad; Hugo Castro-Malaspina; Sergio A Giralt; Ann A Jakubowski; Nancy A Kernan; Richard J O'Reilly; Esperanza B Papadopoulos; James W Young; Marcel R M van den Brink; Glenn Heller; Miguel-Angel Perales
Journal:  Leuk Lymphoma       Date:  2017-01-10

6.  Reduced immunogenicity of the adjuvanted recombinant zoster vaccine after hematopoietic cell transplant: a pilot study.

Authors:  Jose F Camargo; Rick Y Lin; Yoichiro Natori; Anthony D Anderson; Maritza C Alencar; Trent P Wang; Michele I Morris; Krishna V Komanduri
Journal:  Blood Adv       Date:  2020-10-13

7.  Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation.

Authors:  Gregory L Beatty; Jasmine S Smith; Ran Reshef; Kunal P Patel; Theresa A Colligon; Barbara A Vance; Noelle V Frey; F Brad Johnson; David L Porter; Robert H Vonderheide
Journal:  Clin Cancer Res       Date:  2009-07-14       Impact factor: 12.531

8.  Immune reconstitution after allogeneic hematopoietic stem cell transplantation in children: a single institution study of 59 patients.

Authors:  Hyun O Kim; Hyun Jin Oh; Jae Wook Lee; Pil-Sang Jang; Nack-Gyun Chung; Bin Cho; Hack-Ki Kim
Journal:  Korean J Pediatr       Date:  2013-01-29

9.  Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.

Authors:  R M Saliba; K V Komanduri; S Giralt; J de Souza; P Patah; B Oran; D Couriel; G Rondon; R E Champlin; M de Lima
Journal:  Bone Marrow Transplant       Date:  2008-11-17       Impact factor: 5.483

10.  Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation.

Authors:  Ulas D Bayraktar; Denái R Milton; Michele Guindani; Gabriela Rondon; Julianne Chen; Gheath Al-Atrash; Katayoun Rezvani; Richard Champlin; Stefan O Ciurea
Journal:  Biol Blood Marrow Transplant       Date:  2015-10-31       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.